Search results
To Avoid Paxlovid Rebound, Some Experts Call for Longer Courses of Treatment
Time via Yahoo News· 2 years agoCredit - Joe Raedle—Getty Images Prescriptions for the antiviral drug Paxlovid have soared since the...
When and What Day to Test for COVID-19
Verywell Health via Yahoo News· 4 months agoWith Symptoms or After Initial Exposure Medically reviewed by Geetika Gupta, MD If you have been around someone who has tested positive for COVID-19, you...
This Deadly COVID Twist Is Like Nothing We’ve Seen Before
The Daily Beast via Yahoo News· 2 years agoIllustration by Luis G. Rendon/The Daily BeastAs the wave of COVID infections from the...
Arbutus (ABUS) to Focus on Hepatitis B Candidates, Stock Up
Zacks via Yahoo Finance· 8 months agoArbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript February 28, 2024 Atea...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript August 3, 2023 Arbutus...
RedHill Biopharma (RDHL) Up on New Patent for COVID-19 Candidate
Zacks via Yahoo Finance· 2 years agoRedHill Biopharma (RDHL) receives a new patent from the United States Patent and Trademark Office...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2023 Earnings Call Transcript November 14, 2023...
'COVID Isn't Over': Here's What Experts Expect The COVID-19 Pandemic To Be Like This Year
HuffPost via Yahoo News· 1 year agoWith the rise of highly transmissible variants including XBB, experts warn COVID is far from over....
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Motley Fool· 1 year agoWhen the curtain closed on 2022, the ageless Dow Jones Industrial Average, widely followed S&P 500,...